ABSTRACT A composite membrane with nanostructured inorganic and organic phases is applied as an ion-selective layer to improve processability, prevent dendrite shorting, and increase power output of lithium-metal anodes through better Li-ion conductivity. Nanoconfinement, as opposed to macroscale confinement, is known to dramatically alter the properties of bulk materials. … [Read more...] about Microstructured Ion-conducting Composites 2017-012
Uncategorized
Mechanically-Softened, Mass-Loaded, and Chemically-Modified Membranes 2018-081
APPLICATIONS OF TECHNOLOGY: Speaker (earbud, compact, high-intensity, speaker array) Microphone (compact, microphone array) Radar source and/or receiver Positional sensor Echolocation Triangulation Acoustic camera ADVANTAGES: Enables smaller devices Offers broad frequency response ABSTRACT: Membranes of 2D materials (e.g., graphene, other … [Read more...] about Mechanically-Softened, Mass-Loaded, and Chemically-Modified Membranes 2018-081
2018 R&D 100 Award Finalists – Berkeley Lab
The following Berkeley Lab technologies have been named as finalists in the 2018 R&D 100 Award competition: Computing Sciences Area Shifter (Canon, Jacobsen) Energy Sciences Area Smart PV Window (P. Yang) Energy Technologies Area EProject Builder (Larsen) OP1 (co-nominee w/ Opus 12 - Cave, Kuhl) Physical Sciences Area (with co-nominee … [Read more...] about 2018 R&D 100 Award Finalists – Berkeley Lab
Increased Specificity and Sensitivity to Detect Targeted Metabolites using NIMS 2017-051
APPLICATIONS OF TECHNOLOGY: Biological and chemical assays Selective metabolite analysis ADVANTAGES: Increased sensitivity to detect targeted metabolites High selectivity to targeted metabolites Extremely sensitive and non-destructive analytical technique ABSTRACT: Nanostructure-initiator Mass Spectrometry (NIMS) is a surface-based mass … [Read more...] about Increased Specificity and Sensitivity to Detect Targeted Metabolites using NIMS 2017-051
Berkeley Lab – Birthplace of Nuclear Medicine
Berkeley Lab's contribution to the development of nuclear medicine began in the 1930s. John Lawrence, brother of the Lab's founder Ernest Lawrence, treated a leukemia patient with a radioactive isotope in 1936. A year later, researcher Joseph Hamilton was the first to use radioactive tracers to study biological processes in the human body and to address the property -- short … [Read more...] about Berkeley Lab – Birthplace of Nuclear Medicine